Myeloma with specific chromosome change
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This trial studies tissue samples from people with a specific genetic change in their myeloma cells. It aims to better understand this type of myeloma to improve future treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with multiple myeloma.
- Your myeloma has a specific chromosome change called t(4;14).
- A stored tissue sample (from a biopsy or surgery) is available for testing.
- Your diagnosis was made within the last 10 years.
- Your medical records include key clinical and follow-up information.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects stored tissue samples from people with multiple myeloma that has spread outside the bone marrow. The goal is to study these samples to learn more about the disease and possibly find better treatments.
This trial studies myeloma (and closely related blood disorders) by using extra blood or bone marrow samples for lab research. It aims to help discover new ways to understand or treat myeloma.
This trial tests an experimental therapy called CT071 for people with newly diagnosed, high-risk multiple myeloma. It aims to see if this treatment can help control the disease in people who have certain aggressive features.
This study looks at certain genetic changes in patients newly diagnosed with multiple myeloma to understand how they affect the disease. It may help doctors better predict outcomes and tailor treatment in the future.
This trial tests an experimental drug called GR1803 for people with multiple myeloma that has spread to soft tissue areas outside the bone. The goal is to see if it can help shrink these tumors.
This Phase 2/3 trial tests whether matching treatment choices to a patient’s myeloma risk pattern (using blood and scan results) improves outcomes. It is for people with newly diagnosed, untreated, symptomatic multiple myeloma who may also receive transplant-related treatment.
Hear when a new Multiple Myeloma and Malignant Plasma Cell Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.